DOI: https://doi.org/10.14710/jai.v0i0.66384

Role of Neuroprotective Agents in the Anesthetic Management of Brain Tumors for Patients with Recidive Cystic Tumor with Signs of Intracranial Hypertension Underwent Re-Craniotomy Decompression Tumor Resection: Case Report

Department of Anesthesiology & Intensive Therapy, Faculty of Medicine, Universitas Jendral Soedirman/Prof. DR. Margono Soekarjo Hospital, Purwokerto, Indonesia

Received: 1 Sep 2024; Revised: 24 Jan 2024; Accepted: 12 Mar 2024; Available online: 12 Mar 2024; Published: 31 Jul 2025.
Open Access Copyright 2021 JAI (Jurnal Anestesiologi Indonesia)
Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License.

Citation Format:
Cover Image
Abstract

Background: The management of brain tumor surgeries, particularly recurrent cystic tumors with cerebral edema, poses significant challenges. Elevated intracranial pressure (ICP) and the associated risk of ischemia necessitate a comprehensive neuroprotective approach during anesthesia to ensure optimal surgical and postoperative outcomes.

Case: A 54-year-old male presented with two weeks history of headaches and dizziness. He had previously undergone a craniotomy six months ago for the removal of a metastatic right parieto-occipital adenocarcinoma. Imaging revealed tumor recurrence, and the patient was scheduled for a re-craniotomy. The anesthetic plan included neuroprotective strategies: thiopental for metabolic suppression, sufentanil for hemodynamic stability, and sevoflurane for neuroprotection. The surgery lasted 3.5 hours, with minimal intraoperative blood loss and stable perioperative hemodynamics. Postoperatively, the patient recovered without complications and was discharged in stable condition.

Discussion: The anesthetic management prioritized maintaining ICP, cerebral perfusion pressure (CPP), and minimizing neuroinflammatory responses. Thiopental effectively reduced cerebral metabolic demands, sufentanil stabilized hemodynamics, and sevoflurane provided neuroprotective and anti-inflammatory benefits. hypothesis and principles. These strategies ensured cerebral autoregulation, controlled cerebral edema, and optimized recovery. The Monro-Kellie hypothesis and principles of neuroprotection were key guiding frameworks in this case.

Conclusion: This case highlights the critical role of neuroprotective agents in the anesthetic management of brain tumor surgeries. The combination of thiopental, sufentanil, and sevoflurane contributed to a stable intraoperative course and uneventful recovery. Integrating these strategies ensures improved surgical outcomes and patient safety in challenging neurosurgical cases.

Note: This article has supplementary file(s).

Fulltext View|Download |  Research Instrument
Cover Letter
Subject Cover Letter
Type Research Instrument
  Download (19KB)    Indexing metadata
 title page
Title page
Subject title page
Type title page
  Download (15KB)    Indexing metadata
 Research Instrument
Appendix
Subject Informed consent
Type Research Instrument
  Download (597KB)    Indexing metadata
 common.other
Copyright Transfer Agreement
Subject
Type Other
  Download (577KB)    Indexing metadata
Keywords: anesthetic management; intracranial pressure; neuroprotection; sevoflurane; sufentanil; thiopental

Article Metrics:

Article Info
Section: Case Reports
Language : EN
Recent articles
Intrathecal Dexmedetomidine-Fentanyl Combination versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia: A Comparative Study at Haji Adam Malik General Hospital Comparison of The Effects of Fentanyl versus Ketamine on The Quality of Recovery Post General Anesthesia with QoR-40 Scoring in Laparotomy Surgery Colorado Pediatric Airway Score (COPUR) as a Predictor of Intubation Difficulty in Children Aged 1-8 Years Role of Neuroprotective Agents in the Anesthetic Management of Brain Tumors for Patients with Recidive Cystic Tumor with Signs of Intracranial Hypertension Underwent Re-Craniotomy Decompression Tumor Resection: Case Report Thoracic Spinal Anesthesia (TSA) in Patients with Congestive Heart Failure and Pleural Effusion Undergoing Breast Tumor Surgery: A Case Report Nutrition Therapy in Post-Hartmann’s Procedure Patients in The Intensive Care Unit Combination of Vitamin D and Vitamin E Against Bacterial Infections Malignant Hyperthermia More recent articles
Most cited articles
Midazolam Intravena Dosis Rendah Tidak Mempengaruhi Nitric Oxide Intraperitoneal Mencit Balb/C Yang Terpapar Lipopolisakarida Patofisiologi Penyakit Jantung Koroner More cited articles
  1. Privorotskiy A, Bhavsar SP, Lang FF, Hu J, Cata JP. Impact of Anesthesia and Analgesia Techniques on Glioblastoma Progression. A Narrative Review. Neurooncol Adv. 2020 Jan 1;2(1):1–11
  2. Saito J, Masters J, Hirota K, Ma D. Anesthesia and Brain Tumor Surgery. Curr Opin Anaesthesiol. 2019 Oct;32(5):553–62
  3. Slupe AM, Kirsch JR. Effects of Anesthesia on Cerebral Blood Flow, Metabolism, and Neuroprotection. Journal of Cerebral Blood Flow & Metabolism. 2018 Dec 16;38(12):2192–208
  4. Morita T, Shibuta S, Kosaka J, Fujino Y. Thiopental Sodium Preserves the Responsiveness to Glutamate but not Acetylcholine in Rat Primary Cultured Neurons Exposed to Hypoxia. J Neurol Sci. 2016;365:126–31
  5. Turner BK, Wakim JH, Secrest J, Zachary R. Neuroprotective Effects of Thiopental, Propofol, and Etomidate. AANA J. 2005 Aug;73(4):297–302
  6. Madhusudhana R, Aswathappa J, Simha J, Gundappa P, Iyer P. A Comparative Study of Intraoperative Brain Relaxation with Thiopentone & Propofol for Supratentorial Tumour Surgery. IOSR Journal of Dental and Medical Sciences. 2014;13(4):29–31
  7. Bisri DY, Nuryanda D, Alifahna MR, Bisri T. Thiopental-Dexmedetomidine as Adjuvant Anesthesia for Craniotomy Tumor Removal: A Case Report. Jurnal Neuroanestesi Indonesia. 2024 Jun 27;13(2):86–92
  8. Huynh F, Mabasa VH, Ensom MHH. A Critical Review: Does Thiopental Continuous Infusion Warrant Therapeutic Drug Monitoring in the Critical Care Population? Ther Drug Monit. 2009 Apr;31(2):153–69
  9. Weinstabl C, Mayer N, Richling B, Czech T, Spiss CK. Effect of Sufentanil on Intracranial Pressure in Neurosurgical Patients. Anaesthesia. 1991 Oct 22;46(10):837–40
  10. Cafiero T, Mastronardi P. Sufentanyl in Balanced Anesthesia for Neurosurgery. Comparative Study with Fentanyl. Minerva Anestesiol. 2000 Nov;66(11):787–91
  11. Wang Z, Du X, Yu D, Yang Y, Ma G, Jia X, et al. Sufentanil Alleviates Cerebral Ischemia-Reperfusion Injury by Inhibiting Inflammation and Protecting the Blood-Brain Barrier in Rats. European Journal of Histochemistry. 2022 Jan 12;66(1)
  12. Huang D, Luo Z, Song X, Zou K. Global Research on Sufentanil Use in Anesthesiology from 2003 to 2023: A Bibliometric Analysis. Front Pharmacol. 2024 Sep 26;15:1–17
  13. Su S, Ren C, Zhang H, Liu Z, Zhang Z. The Opioid-Sparing Effect of Perioperative Dexmedetomidine Plus Sufentanil Infusion during Neurosurgery: A Retrospective Study. Front Pharmacol. 2016 Oct 26;7:1–9
  14. Fang J, Wang H, Zhang W, Yang K, Wang W. Clinical Observation of Patients Undergoing Glioma Surgery under Propofol and Sevoflurane Anesthesia: A Retrospective Study. J Oncol. 2022 Jun 8;2022:1–6
  15. Sayan HE, Muslu Erdem V, Korfali ŞG. Comparison of Neuroprotective Effect of Isoflurane and Sevoflurane on Cerebral Ischemia. The European Research Journal. 2020 Sep 4;6(5):373–9
  16. Sun M, Xie Z, Zhang J, Leng Y. Mechanistic Insight Into Sevoflurane-associated Developmental Neurotoxicity. Cell Biol Toxicol. 2022 Dec 12;38(6):927–43

Last update:

No citation recorded.

Last update: 2025-08-18 22:34:26

No citation recorded.